Is it justified to exclude patients with minor stroke from intravenous thrombolysis?

International Journal of Stroke

Volumn 8, Issue 3, 2013, Pages

  García García, Jorge ^a   Ayo Martín, Óscar ^a   Segura, Tomas ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE ALBACETE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; WARFARIN;

AGED; APHEMIA; ATAXIC APHASIA; BLOOD CLOT LYSIS; CASE REPORT; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONGESTIVE CARDIOMYOPATHY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; EMERGENCY WARD; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; LETTER; MALE; MEDICAL SOCIETY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PHYSICIAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; SCORING SYSTEM; SPEECH DISORDER; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME;

FIBRINOLYTIC AGENTS; HUMANS; INFUSIONS, INTRAVENOUS; PATIENT SELECTION; RECOMBINANT PROTEINS; SEVERITY OF ILLNESS INDEX; SPEECH DISORDERS; STROKE; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84875253349     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2012.00847.x     Document Type: Letter

References (3)

1. Smith EE, Fonarow GC, Reeves MJetal. Outcomes in mild or rapidly improving stroke not treated with intravenous recombinant tissue-type plasminogen activator. Findings from Get With The Guidelines-Stroke. Stroke 2011; 42:3110-3115.
2. Nedeltchev K, Schwegler B, Haefeli Tetal. Outcome stroke with mild or rapidly improving symptoms. Stroke 2007; 38:2531-2535.
3. Willey JZ, Stillman J, Rivolta JAetal. Too good to treat? Outcomes in patients not receiving thrombolysis du to mild deficits or rapidly improving symptoms. Int J Stroke 2012; 7:202-206.